INFECTIOUS RISKS AND COMPLICATIONS IN ADULT LEUKEMIC PATIENTS RECEIVING BLINATUMOMAB. Mediterr J Hematol Infect Dis [Internet]. 2018 May 1 [cited 2026 Apr. 27];10(1):e2018029. Available from: https://www.mjhid.org/mjhid/article/view/2018.029